Payment overview · 2025
General Payments
2 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · HOMESTEAD, FL · NPI 1245256924
Verified facts
CMS Open Payments records show Leon A Martinez, M.D. received $44.13 in general payments during 2025 across 2 reported records.
Saluda Medical Americas, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
2 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Saluda Medical Americas, Inc. | Unresolved — no canonical attribution shown | $44.13 | 100.0% | 2 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $44.13 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Evoke Normalized: evoke |
Device | Saluda Medical Americas, Inc. | $44.13 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 707 | 214 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 514 | 157 |
| Losartan Potassium | Losartan Potassium | 493 | 147 |
| Gabapentin | Gabapentin | 379 | 108 |
| Metformin Hcl | Metformin Hcl | 375 | 112 |
| Levothyroxine Sodium | Levothyroxine Sodium | 343 | 96 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 329 | 52 |
| Amlodipine Besylate | Amlodipine Besylate | 322 | 96 |
| Lisinopril | Lisinopril | 314 | 96 |
| Metoprolol Succinate | Metoprolol Succinate | 299 | 92 |
| Tamsulosin Hcl | Tamsulosin Hcl | 286 | 87 |
| Famotidine | Famotidine | 269 | 91 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 254 | 82 |
| Eliquis | Apixaban | 221 | 62 |
| Hydrochlorothiazide | Hydrochlorothiazide | 208 | 61 |
| Nifedipine Er | Nifedipine | 189 | 52 |
| Clopidogrel | Clopidogrel Bisulfate | 181 | 56 |
| Alendronate Sodium | Alendronate Sodium | 178 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 178 | 61 |
| Furosemide | Furosemide | 165 | 53 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 156 | 52 |
| Ezetimibe | Ezetimibe | 155 | 55 |
| Fluticasone Propionate | Fluticasone Propionate | 153 | 51 |
| Omeprazole | Omeprazole | 147 | 49 |
| Diclofenac Sodium | Diclofenac Sodium | 135 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 133 | 41 |
| Carvedilol | Carvedilol | 130 | 34 |
| Jardiance | Empagliflozin | 130 | 28 |
| Alprazolam | Alprazolam | 125 | 15 |
| Celecoxib | Celecoxib | 118 | 29 |
| Temazepam | Temazepam | 118 | 14 |
| Montelukast Sodium | Montelukast Sodium | 114 | 39 |
| Finasteride | Finasteride | 113 | 30 |
| Memantine Hcl | Memantine Hcl | 113 | 33 |
| Ammonium Lactate | Ammonium Lactate | 110 | 30 |
| Farxiga | Dapagliflozin Propanediol | 109 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 108 | 25 |
| Ketoconazole | Ketoconazole | 106 | 15 |
| Symbicort | Budesonide/Formoterol Fumarate | 95 | 17 |
| Sertraline Hcl | Sertraline Hcl | 94 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 92 | 32 |
| Allopurinol | Allopurinol | 91 | 27 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 91 | 35 |
| Glipizide | Glipizide | 90 | 24 |
| Glipizide Er | Glipizide | 89 | 23 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 89 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 86 | 13 |
| Simvastatin | Simvastatin | 85 | 31 |
| Ibuprofen | Ibuprofen | 84 | 29 |
| Prednisone | Prednisone | 81 | 43 |
| Trazodone Hcl | Trazodone Hcl | 80 | 23 |
| Latanoprost | Latanoprost | 79 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 79 | 23 |
| Clonidine Hcl | Clonidine Hcl | 76 | 19 |
| Atenolol | Atenolol | 71 | 20 |
| Ozempic | Semaglutide | 71 | 12 |
| Azithromycin | Azithromycin | 63 | 48 |
| Nitroglycerin | Nitroglycerin | 59 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | 15 |
| Donepezil Hcl | Donepezil Hcl | 54 | 17 |
| Sucralfate | Sucralfate | 54 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 52 | 19 |
| Mounjaro | Tirzepatide | 51 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 50 | 20 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 50 | 15 |
| Vascepa | Icosapent Ethyl | 49 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 48 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 39 |
| Clonazepam | Clonazepam | 48 | suppressed |
| Lorazepam | Lorazepam | 48 | suppressed |
| Meloxicam | Meloxicam | 48 | 14 |
| Potassium Chloride | Potassium Chloride | 47 | 14 |
| Lactulose | Lactulose | 46 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 46 | 14 |
| Bumetanide | Bumetanide | 45 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 44 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 42 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 39 | 18 |
| Labetalol Hcl | Labetalol Hcl | 39 | suppressed |
| Spironolactone | Spironolactone | 39 | 14 |
| Mirtazapine | Mirtazapine | 38 | 12 |
| Januvia | Sitagliptin Phosphate | 37 | 11 |
| Alphagan P | Brimonidine Tartrate | 36 | suppressed |
| Methocarbamol | Methocarbamol | 36 | 16 |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 34 | suppressed |
| Naproxen | Naproxen | 34 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 34 | suppressed |
| Xarelto | Rivaroxaban | 34 | suppressed |
| Novolog Flexpen | Insulin Aspart | 33 | suppressed |
| Alcohol Swab | Alcohol Antiseptic Pads | 29 | 29 |
| Baclofen | Baclofen | 29 | suppressed |
| Chlorthalidone | Chlorthalidone | 29 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 29 | suppressed |
| Mupirocin | Mupirocin | 29 | 18 |
| Novolog | Insulin Aspart | 29 | suppressed |
| Entresto | Sacubitril/Valsartan | 28 | suppressed |
| Lidocaine | Lidocaine | 28 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 27 | suppressed |
| Nystatin | Nystatin | 27 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | suppressed |
| Digoxin | Digoxin | 26 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Metolazone | Metolazone | 26 | suppressed |
| Torsemide | Torsemide | 26 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 25 | 19 |
| Ciclopirox | Ciclopirox | 24 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | suppressed |
| Glimepiride | Glimepiride | 23 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 23 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 22 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 22 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Pregabalin | Pregabalin | 20 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 20 | suppressed |
| Lumigan | Bimatoprost | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 18 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 18 | suppressed |
| Levetiracetam | Levetiracetam | 18 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 18 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Humalog | Insulin Lispro | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 16 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Dutasteride | Dutasteride | 15 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 13 | 11 |
| Clobetasol Propionate | Clobetasol Propionate | 13 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Victoza 2-Pak | Liraglutide | 13 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 11 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Xeljanz Xr | Tofacitinib Citrate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $44.13 · 2 records | Saluda Medical Americas, Inc. | Evoke | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error